I just received this email from investorshub:
Sunwin Stevia (OTCQB: SUWN ) Breaking News: Order of over $3.2
Million, New Facility and New Patent
*Sunwin Stevia International Receives a Major Purchase Order of
over $3.2 million for Enzyme-Treated Stevia Products
*Operates a New Manufacturing Facility of 500 Metric Tons of
High–Grade Stevia Increasing its Total Manufacturing Capacity of
High-Grade Stevia to 1,600 Metric Tons per Year
*Sunwin Stevia International to Receive Patent on the Most
Advanced Enzyme-Treated Stevia Products
QUFU, China, June 3, 2015 -- Sunwin Stevia International, Inc. (OTCQB: SUWN, "Sunwin Stevia"), one of the top global suppliers of high quality stevia extracts including Rebaudioside A 98 and Rebaudioside A99, announced today that it has completed construction of a new manufacturing facility that can produce 500 metric tons of high-grade stevia per year. The new facility has been in operation to produce high-grade stevia products on a commercial basis for the market.
In 2014 Sunwin Stevia invested approximately $2 million to start building this new facility in order to meet substantially increased demand for its high-grade stevia products. The new manufacturing facility is fully equipped with stainless steel equipment without any plastic while it has a fully automated system in order to prevent any potential contamination from operators and plastic. In addition, the new manufacturing facility uses the most advanced production equipment that is the first time to be used for stevia production in the industry, such as scraper with centrifuge and fluidized drying system.
As of now, Sunwin Stevia has approximately 1,600 metric tons in manufacturing capacity per year to produce high-grade stevia extract. With these manufacturing facilities, Sunwin Stevia is able to deliver stevia products containing Rebaudioside A in a range of 50% to 99% with a format of powder, granular, or tablet.
Ms. Dongdong Lin, CEO of Sunwin Stevia stated, "We believe Sunwin Stevia becomes the largest manufacturer of high-grade stevia in the world. We expect the total demand for stevia extract will reach a new level in 2016 and beyond. Our state of the art manufacturing facilities lay a solid foundation to grow our stevia business. Our total manufacturing capacity will allow us to grow our annual revenues over $60 million. We will actively market our stevia products in Europe, Asia, South America, and North America to become a dominant global high-grade stevia supplier for years to come.”
Recent News:
Sunwin Stevia International Receives a Major Purchase Order of
$3.2 million for Enzyme-Treated Stevia Products
QUFU, China, May 27, 2015 -- Sunwin Stevia International, Inc. (OTCQB: SUWN, "Sunwin Stevia"), one of the top global providers of high quality stevia extracts including Rebaudioside A 98 and Rebaudioside 99, announced today that it has received a major purchase order of 40 metric tons enzyme-treated stevia products valued over US$3.2 million for the calendar year of 2015 by Wild Flavors, Inc.
Sunwin Stevia International to Receive Patent on the Most
Advanced Enzyme-Treated Stevia Products
QUFU, China, May 27, 2015 -- Sunwin Stevia International, Inc. (OTCQB: SUWN, "Sunwin Stevia"), one of the top global providers of high quality stevia extracts including Rebaudioside A 98 and Rebaudioside A 99, announced today that it has submitted a patent application for its enzyme-treated stevia products.
About Sunwin Stevia International, Inc.
Sunwin Stevia International, Inc. (OTCQB: SUWN) engages in production and distribution of zero calorie, all natural sweeteners (Sunwin Stevia™ Extracts). As an industry leader in high quality stevia production, Sunwin Stevia has built an integrated firm with the farming and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin Stevia, please visit sunwininternational
Safe Harbor Statement
Sunwin Stevia International, Inc. is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward - looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward - looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward - looking statements. These statements include, but are not limited to, our ability to return our revenues to historical levels, our dependence on continued market acceptance of our products, competition, our ability to control our raw material costs, risks associated with operating in China, and other risk factors impacting our company, some of which may be beyond our control. We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward - looking statements we make and that investors should not place undue reliance on any such forward - looking statements. Further, any forward - looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward - looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward - looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the fiscal year ended April 30, 2014.
Contact: §
Peisha Shen
U.S. Representative
Telephone: (954) 363-7333
Facsimile: (954) 363-7320
Email: ir@sunwininternational.com |
Thread abonnieren
